Malik Vikram
- SEC CIK
- 0001730123
No open-market purchases or sales filed in the past year.
Current role at each company
- EOLS Evolus, Inc.Directoras of Feb 19, 2026
- AEON AEON Biopharma, Inc.10% Owneras of Jul 26, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Malik Vikram as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EOLS Evolus, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Malik VikramDirector | SSale | −67.1K | $10.20 | −$684.4K | −5.2%1.23M after | 2 lots |
| Aug 20, 2021 (view filing) | Aug 19-20 | 1 day | Malik VikramDirector | SSale | −61.8K | $10.59 | −$654.8K | −5.0%1.17M after | 2 lots |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Malik VikramDirector | SSale | −26.1K | $11.00 | −$286.8K | −2.2%1.14M after | |
| Aug 15, 2023 (view filing) | Aug 15 | Same day | Malik VikramDirector | PPurchase | +175.0K | $7.41 | +$1.30M | +174.0%275.6K after | |
| May 15, 2024 (view filing) | May 13 | 2 days | Malik VikramDirector | SSale | −28.0K | $12.93 | −$362.0K | −9.9%254.0K after | |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Malik VikramDirector | SSale | −7.50K | $12.96 | −$97.2K | −3.0%246.5K after |